Form 8-K - Current report:
SEC Accession No. 0001213900-23-079136
Filing Date
2023-09-25
Accepted
2023-09-25 16:01:36
Documents
13
Period of Report
2023-09-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea185720-8k_longeveron.htm   iXBRL 8-K 26144
  Complete submission text file 0001213900-23-079136.txt   244025

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lgvn-20230921.xsd EX-101.SCH 3766
3 XBRL DEFINITION FILE lgvn-20230921_def.xml EX-101.DEF 26610
4 XBRL LABEL FILE lgvn-20230921_lab.xml EX-101.LAB 36661
5 XBRL PRESENTATION FILE lgvn-20230921_pre.xml EX-101.PRE 25234
7 EXTRACTED XBRL INSTANCE DOCUMENT ea185720-8k_longeveron_htm.xml XML 5260
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 231275835
SIC: 2834 Pharmaceutical Preparations